Abstract
A new series of isonicotinoyl hydrazone derivatives (3a–3o) have been synthesized, characterized and evaluated for in vitro antimycobacterial activity against M. tuberculosis H37Rv and two clinical isolates using tetrazolium microplate assay (TEMA). Some of these compounds showed moderate to good antimycobacterial activity at micro molar concentrations. Among them, 3k and 3m were the most potent analogues with an inhibition concentration at 0.59 and 0.65 μM, respectively, against M. tuberculosis H37Rv compared to parent drug, isoniazid (0.57 μM). Additionally, all the synthesized compounds were subjected to in vitro anticancer activity against human colorectal cancer cell lines (HCT 116). Compounds 3b and 3l displayed antiproliferative activity at inhibitory concentration 3.1 and 0.29 μM, respectively, when compared to standard, 5-fluorouracil (5 μM). These results can be considered as an important start point for the rational design of new leads for antitubercular and anticancer drug discovery.
Similar content being viewed by others
References
Caviedes L, Delgado J, Gilman RH (2002) Tetrazolium microplate assay as a rapid and inexpensive colorimetric method for determination of antibiotic susceptibility of Mycobacterium tuberculosis. J Clin Microbiol 40:1873–1874
Demirbas N, Karaoglu SA, Demirbas A, Sancak K (2004) Synthesis and antimicrobial activities of some new 1-(5-phenylamino-[1,3,4] thiadiazol-2-yl) methyl-5-oxo-[1,2,4] triazole and 1-(4-phenyl-5-thioxo-[1,2,4] triazol-3-yl) methyl-5-oxo-[1,2,4] triazole derivatives. Eur J Med Chem 39:793–804
Ellner JJ, Goldberger MJ, Parenti DM (1991) Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution. J Infect Dis 163:1326–1335
Emami S, Foroumadi A, Lotfali ME, Rajabalian S, Ebrahimi A, Farahyar S, Shafiee A (2008) 2-Hydroxyphenacyl azoles and related azolium derivatives as antifungal agents. Bioorg Med Chem Lett 18:141–146
Ferreira ML, de Cardoso F, Laura N, Goncalves RSB, da Silva ET, Lourenco MCS, Vicente FR, de Souza MVN (2008) Synthesis and antitubercular evaluation of N-[(E)-(hydroxy, methoxy and ethoxy-substituted-phenyl) methylidene] isonicotinohydrazide derivatives. Lett Drug Des Discov 5:137–140
Gurkok G, Altanlar N, Suzen S (2009) Investigation of antimicrobial activities of indole-3-aldehyde hydrazide/hydrazone derivatives. Chemotherapy 55:15–19
Junior IN, Lourenco M, Henriques MGMO, Ferreira B, Vasconcelos TRA, Peralta MA, de Oliveira PSM, Wardell SMSV, de Souza MVN (2005) Synthesis and anti-mycobacterial activity of N-[(E)-(disubstituted-phenyl) methylidene]isonicotino-hydrazide derivatives. Lett Drug Des Discovery 2:563–566
Kaymakc¸ıog˘lu BK, Oruc E, Unsalan S, Kandemirli F, Shvets N, Rollas S, Dimoglo A (2006) Synthesis and characterization of novel hydrazide–hydrazones and the study of their structure antituberculosis activity. Eur J Med Chem 41:1253–1261
Kaymakc¸ıog˘lu BK, Emre EEO, Unsalan S, Rollas S (2009) Antituberculosis activity of hydrazones derived from 4-fluorobenzoic acid hydrazide. Med Chem Res 18:277–286
Lourenaso MCS, Ferreira ML, de Souza MVN, Peralta MA, Vasconcelos TRA, Henriques MGMO (2008) Synthesis and antimycobacterial activity of (E)-N′-(mono substituted benzylidene)isonicotinohydrazide derivatives. Eur J Med Chem 43:1344–1347
Maccari R, Ottana R, Vigorita MG (2005) In vitro advanced antimycobacterial screening of isoniazid related hydrazones, hydrazides and cyanoboranes: part 14. Bioorg Med Chem Lett 15:2509–2513
Mital A, Negi VS, Ramachandran U (2006) Synthesis and antimycobacterial activities of certain trifluoromethyl-aminoquinoline derivatives. ARKIVOC 10:220–227
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63
Mshana RN, Tadesse G, Abate G, Håkan M (1998) Use of 3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide for rapid detection of rifampin-resistant Mycobacterium tuberculosis. J Clin Microbiol 36:121–1214
Narasimhan B, Narang R, Judge V, Ohlan S, Ohlan R (2007) Synthesis, antimicrobial and QSAR studies of substituted anilides. ARKIVOC 15:112–126
Naveenkumar HS, Sadikun A, Ibrahim P, Loh WS, Fun HK (2009) (E)-N′-(3-Benzyloxy-4- methoxy benzylidene)isonicotinohydrazide. Acta Crystallogr Sect E: Struct Rep Online 65:o2540–o2541
Naveenkumar HS, Sadikun A, Ibrahim P, Goh JH, Fun HK (2010a) (E)-N’-(2,4,6-Trimethyl benzylidene)isonicotinohydrazide. Acta Crystallogr Sect E: Struct Rep Online 66:o1493–o1493
Naveenkumar HS, Sadikun A, Ibrahim P, Goh JH, Fun HK (2010b) (E)-N’-(2,3,4-Trihydroxy benzylidene) isonicotinohydrazide dihydrate. Acta Crystallogr Sect E: Struct Rep Online 66:o3017–o3018
Naveenkumar HS, Sadikun A, Ibrahim P, Hemamalini M, Fun HK (2010c) (E)-N’-(2-Benzyloxy benzylidene)isonicotinohydrazide methanol solvate monohydrate. Acta Crystallogr Sect E: Struct Rep Online 66:o1337–o1338
Naveenkumar HS, Sadikun A, Ibrahim P, Loh WS, Fun HK (2010d) (E)-N’-(2, 4, 6-Trihydroxy benzylidene)isonicotinohydrazide sesquihydrate. Acta Crystallogr Sect E: Struct Rep Online 66:o1202–o1203
Naveenkumar HS, Sadikun A, Ibrahim P, Loh WS, Fun HK (2010e) (E)-N’-[(E)-2-Methylpent-2-enylidene]isonicotinohydrazide. Acta Crystallogr Sect E: Struct Rep Online 66:o1489–o1490
Naveenkumar HS, Sadikun A, Ibrahim P, Yeap CS, Fun HK (2010f) (E)-N’-(2,3,4-Trimethoxy benzylidene) isonicotinohydrazide. Acta Crystallogr Sect E: Struct Rep Online 66:o1231–o1232
Naveenkumar HS, Sadikun A, Ibrahim P, Quah CK, Fun HK (2010g) (E)-N’-[(E)-3-(4-Hydroxy-3-methoxyphenyl)allylidene]isonicotinohydrazide. Acta Crystallogr Sect E: Struct Rep Online 66:o291–o291
Naveenkumar HS, Sadikun A, Ibrahim P, Yeap CS, Fun HK (2010h) (E)-N’-(2,4,5-Trifluoro benzylidene)isonicotinohydrazide monohydrate. Acta Crystallogr Sect E: Struct Rep Online 66:o579–o579
Naveenkumar HS, Sadikun A, Ibrahim P, Yeap CS, Fun HK (2010i) (E)-N’-(2,4,5-Trimethoxy benzylidene)isonicotinohydrazide dihydrate. Acta Crystallogr Sect E: Struct Rep Online 66:o1235–o1236
Naveenkumar HS, Sadikun A, Ibrahim P, Yeap CS, Fun HK (2010j) Bis {(E)-N’-[2,4-bis(trifluoro methyl)benzylidene]isonicotinohydrazide}monohydrate. Acta Crystallogr Sect E: Struct Rep Online 66:o1918–o1919
Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108
Pavan FR, da S. Maia PI, Leite SRA, Deflon VM, Batista AA, Sato DN, Franzblau SG, Leite CQF (2010) Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide/hydrazones: anti mycobacterium tuberculosis activity and cytotoxicity. Eur J Med Chem 45:1898–1905
Rollas S, Küçükgüzel ŞG (2007) Biological activities of hydrazone derivatives. Molecules 12:1910–1939
Schwab CE, Tuschl H (2003) In vitro studies on the toxicity of isoniazid in different cell lines. Hum Exp Toxicol 22:607–615
Sharma P, Rane N, Gurram VK (2004) Synthesis and QSAR studies of pyrimido(4,5-d)pyrimidine-2,5-dione derivatives as potential antimicrobial agents. Bioorg Med Chem Lett 14:4185–4190
Sinha N, Jain S, Tilekar A, Upadhayaya RS, Kishore N, Jana HG (2005) Synthesis of isonicotinic acid N′-arylidene-N-[2-oxo-2-(4-aryl-piperazin-1-yl)-ethyl]-hydrazides as antituberculo sis agents. Bioorg Med Chem Lett 15:1573–1576
Sztanke K, Tuzimski T, Rzymowska J, Pasternak K, Kandefer-Szersze AM (2008) Synthesis, determination of the lipophilicity, anticancer and antimicrobial properties of some fused 1,2,4-triazole derivatives. Eur J Med Chem 43:404–419
Tripathi RP, Saxena N, Tiwari VK, Verma SS, Chaturvedi V, Manju YK, Srivastva AK, Gaikwad A, Sinha S (2006) Synthesis and antitubercular activity of substituted phenylmethyl- and pyridylmethyl amines. Bioorg Med Chem 14:8186–8196
Vicini P, Incerti M, Doytchinova IA, La Colla P, Busonera B, Loddo R (2006) Synthesis and anti proliferative activity of benzo [d] isothiazole hydrazones. Eur J Med Chem 41:624–632
Whitney JB, Wainberg MA (2002) Isoniazid, the frontline of resistance in Mycobacterium tuberculosis. McGill J Med 6:114–123
World Health Organization Cancer Fact Sheet (2012) http://www.who.int/mediacentre/factsheets/fs297/en/. Accessed 29 Oct 2012
World Health Organization http://www.who.int/topics/tuberculosis/en/. Accessed 5 Aug 2012
World Health Organization Tuberculosis Fact Sheet (2011) http://www.who.int/tb/publications/2011/factsheet_tb_2011.pdf. Accessed 19 Sept 2012
Acknowledgments
The authors wish to thank Suriyati Mohamed and Dr. Siti Suraiya Md. Noor, Department of Medical Microbiology and Parasitology, School of Medical Sciences, University of Science Malaysia (USM) for providing MTB clinical isolates. The authors also wish to thank EMAN Testing and Research Laboratory, School of Pharmaceutical Sciences, USM for assisting in conducting in vitro anticancer assay. This research is supported by USM under the Research University Grant (1001/PFARMASI/815005). Naveen Kumar and Thaigarajan are thankful to University of Science Malaysia, for providing USM-fellowship.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Naveen Kumar, H.S., Parumasivam, T., Jumaat, F. et al. Synthesis and evaluation of isonicotinoyl hydrazone derivatives as antimycobacterial and anticancer agents. Med Chem Res 23, 269–279 (2014). https://doi.org/10.1007/s00044-013-0632-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-013-0632-2